Search This Blog

Monday, June 2, 2014

Data on Merck’s Pembrolizumab from Largest Study to Date of Investigational Anti-PD-1 Antibody in Advanced Melanoma Highlighted at ASCO 2014 | Merck Newsroom Home

Data on Merck’s Pembrolizumab from Largest Study to Date of Investigational Anti-PD-1 Antibody in Advanced Melanoma Highlighted at ASCO 2014 | Merck Newsroom Home

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.